Adverse Effect Reduction

Adverse Effect Reduction is a clinical strategy within opioid rotation that comprises the deliberate substitution of one opioid for another to diminish the incidence or severity of treatment-limiting side effects while maintaining analgesic efficacy.

439

Publications

20.2K

Citations

2.1K

Authors

814

Institutions

Publications per year

2017–2026

132

Authors

2.1K

  1. CC
    Connie Chen

    Pfizer (United States), United States

    3 publications · 254 citations

    3

    h-index

  2. HO
    H. Oğuz

    Selçuk University, Türkiye

    3 publications · 338 citations

    3

    h-index

  3. HL
    Herbert L. DuPont

    The University of Texas Health Science Center at Houston, United States

    2 publications · 344 citations

    2

    h-index

  4. FP
    Francesca Polito

    University of Messina, Italy

    2 publications · 179 citations

    2

    h-index

  5. HM
    Herbert Marini

    University of Messina, Italy

    2 publications · 179 citations

    2

    h-index

1–5 of 2.1K

Venues

  1. PubMed

    Repository · 42 publications · 1.5K citations

    19

    h-index

  2. JAMA

    8 publications · 937 citations

    8

    h-index

  3. Neurology

    7 publications · 570 citations

    7

    h-index

  4. Annals of Pharmacotherapy

    4 publications · 134 citations

    4

    h-index

  5. BMJ

    3 publications · 282 citations

    3

    h-index

1–5